Nephrology Times

09/12/2025

For our latest "5 Nephrologists, 1 Question" feature, we asked five nephrologists: Are you on X or Bluesky? And why?

In this recurring section, Nephrology Times asked five nephrologists: Are you on X or Bluesky? What are your reasons for using or not using each social media platform?

09/11/2025

Researchers uncovered serum proteome biomarkers to predict eGFR decline in patients with autosomal polycystic kidney disease.

Research uncovered serum proteome biomarkers to predict estimated glomerular filtration rate (eGFR) decline in patients with autosomal dominant polycystic kidney disease (ADPKD).

09/09/2025

Proposed causes of eGFR difference did not account for its association with adverse outcomes in CKD.

09/08/2025

OUT NOW! Our September issue includes kidney care and the environment, World Transplant Congress highlights, felzartamab for IgAN, KDIGO CKD guideline considerations, and more. https://buff.ly/gLZYvLR

09/08/2025

Crescents and cellular segmental sclerosis predicted greater benefit from in .

09/07/2025

Sarah Tolson provides insights on billing and reimbursement issues in her regular column. Catch up here 👉 https://buff.ly/oOSvwMa

09/06/2025

DID YOU KNOW? We cover highlights of major conferences. Find our coverage here ➡️ https://www.docwirenews.com/page/nephrology-times-conference-coverage

09/01/2025

🩺 Happy Labor Day to our US readers!

08/31/2025

📩 ARE YOU ON THE LIST? To get our email updates, sign up here 👉 https://buff.ly/hxhibe3

08/30/2025

ICYMI: We recently hosted our first roundtable. Watch the panel discuss the evolving landscape of C3G/IC-MPGN. ➡️ https://buff.ly/xQPd7tj

08/29/2025

Real-world data provided strong evidence supporting GLP-1 RA use in patients with diabetes receiving dialysis.

08/28/2025

A study shed light on the association between childhood cancer treatment and CKD or hypertension after treatment.